Severe local skin reaction after the application of ingenol mebutate gel treated by photodynamic therapy: A case report

Luca Negosanti, Rossella Sgarzani, Matteo Santoli, Massimino Negosanti, Nicoletta Banzola, Francesca Negosanti

Abstract


Ingenol mebutate (IM) was recently introduced for the treatment of actinic keratosis (AK). It is considered a safe and effective treatment in spite of local reactions frequently reported. These reactions may consist of erythema, flaking, crusting, swelling, vesicles and erosions, and would usually spontaneously recede within 20–30 days. We reported a case of a patient affected by multiple actinic keratosis of the scalp treated with IM. The patient reported a severe reaction that was not solved in two months. We decided to treat the reaction with photodynamic therapy and aminolevulinic acid. This treatment was demonstrated to be effective in solving this severe side effect.


Keywords


actinic keratosis; ingenol mebutate; photodynamic therapy

Full Text:

PDF

References


Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366: 1010–1019. doi: 10.1056/NEJMoa1111170.

Longo C, Neri L, Argenziano G, Calvieri S, Calzavara- Pinton PG, et al. Management of local skin reactions after the application of ingenol mebutate gel for the treatment of actinic keratosis: Four illustrative cases. J Eur Acad Der-matol Venereol 2014; 30(2): 320–321. doi:10.1111/jdv. 12714.

Negosanti L, Pinto V, Sgarzani R, Negosanti F, Zannetti G, et al. Photodynamic therapy with topical aminolevulinic acid. World J Dermatol 2014; 3(2): 6–14. doi: 10.5314/ wjd.v3.i2.6.

Berman B, Nestor MS, Newburger J, Park H, Swenson N. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebu-tate 0.015% gel with and without prior treatment with ALA-PDT. J Drugs Dermatol 2014; 13(11): 1353–1356.

Pariser DM, Eichenfield LF, Bukhalo M, Waterman G, Jarratt M, et al. Photodynamic therapy with 80 mg/g me-thyl aminolaevulinate for severe facial acne vulgaris: A randomised vehicle-controlled study. Br J Dermatol 2015. doi: 10.1111/bjd.14345.


Refbacks

  • There are currently no refbacks.